Increased Cortical Inhibition in Autism-Linked Neuroligin-3R451C Mice Is Due in Part to Loss of Endocannabinoid Signaling
- PMID: 26469287
- PMCID: PMC4607423
- DOI: 10.1371/journal.pone.0140638
Increased Cortical Inhibition in Autism-Linked Neuroligin-3R451C Mice Is Due in Part to Loss of Endocannabinoid Signaling
Abstract
A single, maternally inherited, X-linked point mutation leading to an arginine to cysteine substitution at amino acid 451 (R451C) of Neuroligin 3 (NLGN3R451C) is a likely cause of autism in two brothers. Knockin mice expressing the Nlgn3R451C mutation in place of wild-type Nlgn3 demonstrate increased inhibitory synaptic strength in somatosensory cortex, resulting in an excitatory/inhibitory (E/I) imbalance that is potentially relevant for autism-associated behavioral deficits characteristic of these mice. We have replicated the increase in evoked inhibitory postsynaptic currents (eIPSCs) onto layer II/III cortical pyramidal neurons. We also find that increased frequency of spontaneous mIPSCs in Nlgn3R451C mice occurs in the absence of action potential-driven transmission. This suggests the E/I imbalance is due to changes at the synapse level, as opposed to the network level. Next, we use paired whole-cell recordings in an attempt to identify specific interneuron subtypes affected by the Nlgn3R451C mutation. Curiously, we observe no change in the amplitude of cell-to-cell, unitary IPSCs (uIPSCs) from parvalbumin-positive (PV) or somatostatin-positive (SOM) interneurons onto pyramidal neurons. We also observe no change in the number or density of PV and SOM interneurons in LII/III of somatosensory cortex. This effectively rules out a role for these particular interneurons in the increased inhibitory synaptic transmission, pointing to perhaps alternative interneuron subtypes. Lastly, impaired endocannabinoid signaling has been implicated in hippocampal synaptic dysfunction in Nlgn3R451C mice, but has not been investigated at cortical synapses. We find that bath application of the CB1 antagonist, AM 251 in WT mice eliminates the Nlgn3R451C increase in eIPSC amplitude and mIPSC frequency, indicating that increased inhibitory transmission in mutant mice is due, at least in part, to a loss of endocannabinoid signaling through CB1 receptors likely acting at interneurons other than PV or SOM.
Conflict of interest statement
Figures
![Fig 1](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/4607423/bin/pone.0140638.g001.gif)
![Fig 2](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/4607423/bin/pone.0140638.g002.gif)
![Fig 3](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/4607423/bin/pone.0140638.g003.gif)
![Fig 4](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/4607423/bin/pone.0140638.g004.gif)
![Fig 5](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/4607423/bin/pone.0140638.g005.gif)
![Fig 6](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/4607423/bin/pone.0140638.g006.gif)
Similar articles
-
Neuroligins Are Selectively Essential for NMDAR Signaling in Cerebellar Stellate Interneurons.J Neurosci. 2016 Aug 31;36(35):9070-83. doi: 10.1523/JNEUROSCI.1356-16.2016. J Neurosci. 2016. PMID: 27581450 Free PMC article.
-
[Synapse maturation and autism: learning from neuroligin model mice].Nihon Shinkei Seishin Yakurigaku Zasshi. 2014 Feb;34(1):1-4. Nihon Shinkei Seishin Yakurigaku Zasshi. 2014. PMID: 25069265 Review. Japanese.
-
Autism-associated neuroligin-3 mutations commonly disrupt tonic endocannabinoid signaling.Neuron. 2013 May 8;78(3):498-509. doi: 10.1016/j.neuron.2013.02.036. Epub 2013 Apr 11. Neuron. 2013. PMID: 23583622 Free PMC article.
-
A review on the current neuroligin mouse models.Sheng Li Xue Bao. 2012 Oct 25;64(5):550-62. Sheng Li Xue Bao. 2012. PMID: 23090496 Review.
-
Autism-linked neuroligin-3 R451C mutation differentially alters hippocampal and cortical synaptic function.Proc Natl Acad Sci U S A. 2011 Aug 16;108(33):13764-9. doi: 10.1073/pnas.1111093108. Epub 2011 Aug 1. Proc Natl Acad Sci U S A. 2011. PMID: 21808020 Free PMC article.
Cited by
-
The endocannabinoid system as a putative target for the development of novel drugs for the treatment of psychiatric illnesses.Psychol Med. 2023 Nov;53(15):7006-7024. doi: 10.1017/S0033291723002465. Epub 2023 Sep 6. Psychol Med. 2023. PMID: 37671673 Free PMC article. Review.
-
Individually tailored dosage regimen of full-spectrum Cannabis extracts for autistic core and comorbid symptoms: a real-life report of multi-symptomatic benefits.Front Psychiatry. 2023 Aug 21;14:1210155. doi: 10.3389/fpsyt.2023.1210155. eCollection 2023. Front Psychiatry. 2023. PMID: 37671290 Free PMC article.
-
Transition from Animal-Based to Human Induced Pluripotent Stem Cells (iPSCs)-Based Models of Neurodevelopmental Disorders: Opportunities and Challenges.Cells. 2023 Feb 7;12(4):538. doi: 10.3390/cells12040538. Cells. 2023. PMID: 36831205 Free PMC article. Review.
-
Neurexins and their ligands at inhibitory synapses.Front Synaptic Neurosci. 2022 Dec 21;14:1087238. doi: 10.3389/fnsyn.2022.1087238. eCollection 2022. Front Synaptic Neurosci. 2022. PMID: 36618530 Free PMC article. Review.
-
Neuroligin-3: A Circuit-Specific Synapse Organizer That Shapes Normal Function and Autism Spectrum Disorder-Associated Dysfunction.Front Mol Neurosci. 2021 Oct 6;14:749164. doi: 10.3389/fnmol.2021.749164. eCollection 2021. Front Mol Neurosci. 2021. PMID: 34690695 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases